Haraldsdottir Sigurdis, Einarsdottir Hulda M, Smaradottir Agnes, Gunnlaugsson Adalsteinn, Halfdanarson Thorvardur R
Laeknabladid. 2014 Feb;100(2):75-82. doi: 10.17992/lbl.2014.02.531.
Colorectal cancer is the third most common cancer in the Western hemisphere and the incidence increases with increasing age. Most colorectal cancers are localized with or without lymph node metastases. Up to 20% of patients present with metastatic disease, most commonly to the liver. Surgery is the only curative therapy for localized colorectal cancer and adjuvant chemotherapy is usually recommended for patients with lymph node metastases. Surgery, radiation therapy and chemotherapy are the key components of rectal cancer therapy. Selected patients with recurrent and metastatic disease can be salvaged with surgery but chemotherapy remains the mainstay of therapy for advanced colorectal cancer. Substantial progress has been observed in the treatment of metastatic colorectal cancer in recent years.
结直肠癌是西半球第三常见的癌症,其发病率随年龄增长而增加。大多数结直肠癌局限存在,伴或不伴有淋巴结转移。高达20%的患者出现转移性疾病,最常见转移至肝脏。手术是局限性结直肠癌的唯一治愈性疗法,对于有淋巴结转移的患者通常推荐辅助化疗。手术、放疗和化疗是直肠癌治疗的关键组成部分。部分复发和转移性疾病患者可通过手术挽救,但化疗仍然是晚期结直肠癌治疗的主要手段。近年来,转移性结直肠癌的治疗取得了显著进展。